文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

结核流行区大型多中心研究:副结核分枝杆菌与克罗恩病的关联

Association of Mycobacterium avium paratuberculosis With Crohn's Disease: A Large Multicenter Study From a Tuberculosis-Endemic Region.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该研究在印度7家三级中心纳入148例新诊断未治疗克罗恩病、288例肠结核、251例溃疡性结肠炎及202例非炎症性肠病对照,采用血清学、PCR、培养及组织学方法检测副结核分枝杆菌(MAP)。结果显示克罗恩病患者MAP血清阳性率和组织PCR阳性率显著高于对照组,提示MAP与克罗恩病存在关联。

要点

  • 克罗恩病患者MAP血清阳性率20.6%,显著高于肠结核7.8%、溃疡性结肠炎4.8%及健康对照16.2%。
  • 结肠活检组织IS900 PCR在克罗恩病阳性率11%,显著高于溃疡性结肠炎1%和肠结核0.5%。
  • 活检组织固体培养克罗恩病MAP阳性率10%,高于肠结核4.1%和溃疡性结肠炎0%。

核心结论

  • 研究提示克罗恩病与MAP存在增强的关联,未来需探索MAP的因果作用及靶向治疗选择。

研究设计与样本

  • 多中心观察性研究,在印度7家三级中心纳入新诊断未治疗克罗恩病148例、肠结核288例、溃疡性结肠炎251例及非炎症性肠病对照202例,共889人。

主要发现

  • MAP血清阳性率在克罗恩病为20.6%(13/63),健康对照16.2%(12/74),肠结核7.8%(9/116),溃疡性结肠炎4.8%(4/84),P < .01。
  • 结肠活检组织IS900 PCR阳性率在克罗恩病为11%(9/82),健康对照7.1%(5/70),溃疡性结肠炎1%(2/188),肠结核0.5%(1/198),P < .01。
  • 活检组织固体培养MAP阳性率在克罗恩病为10%(5/50),肠结核4.1%(4/97),溃疡性结肠炎0%(0/78),P = .02。
  • 液体培养、免疫组化、原位PCR及血PCR分析未观察到组间差异。

临床怎么用

  • 在结核流行区,MAP检测结果需结合肠结核鉴别诊断综合解读,不能单独作为克罗恩病诊断依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The causal relationship between Crohn's disease (CD) and Mycobacterium avium subspecies paratuberculosis (MAP) remains controversial. METHODS: This multicenter observational study, conducted across 7 tertiary care centers in India, enrolled newly diagnosed, treatment-naive patients with CD as cases and treatment-naive patients with intestinal tuberculosis (ITB) or ulcerative colitis (UC) and healthy individuals undergoing sigmoidoscopy for hemorrhoids as controls. MAP detection was performed using serology for MAP antibodies, polymerase chain reaction (PCR), real-time quantitative PCR, and solid/liquid cultures of blood and colonic biopsy specimens. In situ PCR and immunohistochemistry were also applied to paraffin-embedded tissue sections to evaluate the presence of MAP across groups. RESULTS: A total of 889 participants were recruited (148 with CD, 288 with ITB, 251 with UC, and 202 controls without inflammatory bowel disease) were included. The seropositivity of MAP was significantly higher in patients with CD than in controls (20.6% [13 of 63] vs 16.2% [12 of 74] for healthy controls, 7.8% [9 of 116] for patients with ITB, and 4.8% [4 of 84] for patients with UC; P < .01). With tissue PCR analysis using a IS900-specific sequence with colonic biopsy specimens, a significantly higher number of patients with CD were positive for MAP compared with controls (11% [9 of 82] vs 7.1% [5 of 70] for healthy controls, 1% [2 of 188] for patients with UC, and 0.5% [1 of 198] for patients with ITB; P < .01). On solid culture of biopsy samples, MAP was detected in 10% of patients with CD (5 of 50), compared with 4.1% (4 of 97) for ITB and 0% (0 of 78) for UC (P = .02). However, this difference was not observed with analysis using liquid culture, immunohistochemistry, in situ PCR, or PCR of blood samples. CONCLUSIONS: Our study findings suggest an increased association between MAP and CD. Future studies should explore the possible causal role of MAP in CD and potential therapeutic options to target MAP.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Vuyyuru SK, Singh U, Das P, et al. Association of Mycobacterium avium paratuberculosis With Crohn's Disease: A Large Multicenter Study From a Tuberculosis-Endemic Region. Clin Infect Dis. 2026. PMID: 41488976. doi:10.1093/cid/ciaf738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。